Ming Xia

Publication Activity (10 Years)

Years Active: 2022-2024
Publications (10 Years): 4

Top Topics

Plasmodium Falciparum

Immune Response

Top Venues

This page only lists publications with an associated author ORCID identifier.

Publications

Pengwei Huang, Ming Xia, Frank S Vago, Wen Jiang, Ming Tan
A Pseudovirus Nanoparticle Displaying the Vaccinia Virus L1 Protein Elicited High Neutralizing Antibody Titers and Provided Complete Protection to Mice against Mortality Caused by a Vaccinia Virus Challenge. Vaccines 12 (8) (2024)
Casey Hensley, Charlotte Nyblade, Peng Zhou, Viviana Parreño, Ashwin K Ramesh, Annie Frazier, Maggie Frazier, Sarah Garrison, Ariana Fantasia-Davis, Ruiqing Cai, Peng-Wei Huang, Ming Xia, Ming Tan, Lijuan Yuan
Combined Live Oral Priming and Intramuscular Boosting Regimen with Rotarix ® and a Nanoparticle-Based Trivalent Rotavirus Vaccine Evaluated in Gnotobiotic Pig Models of G4P[6] and G1P[8] Human Rotavirus Infection. Vaccines 11 (5) (2023)
Ming Xia, Pengwei Huang, Frank Vago, Wen Jiang, Ming Tan
Pseudovirus Nanoparticles Displaying Plasmodium Circumsporozoite Proteins Elicited High Titers of Sporozoite-Binding Antibody. Vaccines 11 (11) (2023)
Ming Xia, Pengwei Huang, Ming Tan
A Pseudovirus Nanoparticle-Based Trivalent Rotavirus Vaccine Candidate Elicits High and Cross P Type Immune Response. Pharmaceutics 14 (8) (2022)